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Abstract: 
Background: Lower respiratory tract infections (LRTI) including pneumonia represent inflammatory conditions of 
the lungs i.e of the pleura, bronchioles, air-sacs and parenchyma.1 
Objective: To determine the improvement in condition of children with lower respiratory infection with vitamin D 
supplementation  
Methods: Hundred pneumonia patients received antibiotics and vitamin D (100,000 IU) while another group of 
hundred patients received only antibiotics without vitamin supplementation. When respiratory distress settled, total 
days of treatment in the ward were calculated and patients were discharged. Each of these was kept under proper 
followed-up for 3 months after treatment to pick LRTI recurrence if any. 
Results: The mean recovery time for vitamin D group (5.7 +2.8 days) and non-vitamin D (6.1 +2.8 days) was 
almost same with P=0.29. But the frequency of repeated episodes of pneumonia within 30 days of treatment was 
lower in intervention group n=4 (2%) than the non-intervention group n=18 (9%) (P = 0.002). 
Conclusion: 100,000 IU of vitamin D given once during treatment of LRTI decreases the chances of recurrence in 
the next 30 days. 
Keywords: Vitamin D supplement, LRTI, Pneumonia, Vitamin D deficiency. 
Corresponding author:  
Muhammad Arslan, 
Medical Officer, Regional Health Center, Faisalabad, Pakistan,  
Email: arslananwar93@gmail.com 
 
 
 
Please cite this article in press Muhammad Arslan et al., Vitamin D Supplementation Protect Children From 
Lower Respiratory Tract Infection: A Controlled Trial., Indo Am. J. P. Sci, 2019; 06(03). 
 
 
 
 
QR code 
 
 
IAJPS 2019, 06 (03), 1-7                      Muhammad Arslan et al                         ISSN 2349-7750 
 
 
w w w . i a j p s . c o m  
 
Page 6098 
INTRODUCTION: 
Lower respiratory tract infections (LRTI) including 
pneumonia represent inflammatory conditions of the 
lungs i.e of the pleura, bronchioles, air-sacs and 
parenchyma. These infections lead to major 
morbidity and mortality in children in developing 
nations.[1,2] Patients presents with fever, cough, 
tachypnea and breathing difficulty. Clinical 
examination of the chest and plain x-ray of the chest 
is required for diagnosis.[2] Infants with severe 
respiratory tract infection may develop cyanosis, 
grunting and poor respiratory effort.  Older children 
may present with associated chest pain or 
gastrointestinal symptoms as abdominal pain, 
vomiting, diarrhea, anorexia.[1] 
According to an estimate by a renowned organization 
more than one and a half million pneumonia patients 
are seen in an year and children of less than 5 years 
of age and about 20 million cases requiring hospital 
admission.[3] Around 7 – 13% of these cases are 
serious enough that can lead to drastic results if not 
properly managed. Pneumonia is the main etiology 
behind the mortality of patients of age < 5 years, 
about one and a half million  patients die of 
pneumonia every year (18% of total deaths).[4, 5] 
Activated vitamin D3 promotes growth of bones, 
especially in growing children and deficiency can 
lead to vitamin D deficiency rickets. Deficient of 
vitamin D in children make them more prone to 
develop respiratory infections.[6] Sunlight exposure 
of the skin promotes the synthesis and activation of 
vitamin D for body use. Various dietary sources of 
vitamin D include egg yolk and сod liver oil.[7] 
Binding of activated cholecalciferol to specific 
receptors promotes the synthesis of cathecilidins, 
these are integral part of innate immunity in the 
body.[8] Activated cholicalceferol also promotes 
monocyte production and there conversion into 
macrophages, thus promoting body’s immune 
response.[9] Charan et al reported that 21.8% patients 
on vitamin D supplementation vs 30% patients in 
non-vitamin D supplemented group had recurrent 
infections.[9] Semira Manaseki-Holland et al 
reported that pneumonia recurrence in 3 months after 
discharge was 45% vitamin D supplemented 
(100,000 IU) children compared to 58% in the 
control group; but no additional effect on the duration 
of hospital stay.[10] 
Salem M. Banajeh reported that compared to normal 
children rickets is associated with fourfold increase 
chances of treatment failure.[11] Bergman P et al 
reported that the patients with vitamin D 
supplementation had less number of positive 
microbiological findings and bacterial cultures (36% 
vs. 41%) than the placebo group. These findings 
significantly support the preventive role of vitamin D 
from infections in the body and possibly diminish the 
duration of antibiotic required.[12]  
Roth DE et al studied polymorphisms in the gene 
encoding for vitamin D rickets had strong association 
with increased risk of infection of the lower 
respiratory tract.[13]  Choudhary N and Gupta P 
reported that supplementation of vitamin D orally for 
five days has no benefit in patients of less than five 
years with severe pneumonia.[14] 
Manaseki-Holland S et al concluded after a study that 
stat doses of vitamin D given orally in children after 
every quarter was not effective in the reduction of the 
incidence and severity of pneumonia in those 
infants.[8] 
We designed a study to test the hypothesis that 
100,000 units of vitamin D3 supplementation once on 
the first day of admission in children with pneumonia 
decreases the duration of hospitalization. In addition, 
it also decreases the recurrence of pneumonia within 
three months following the episode of lower 
respiratory tract infection. 
PATIENTS & METHOD: 
Two hundred children with pneumonia and low 
vitamin D level (< 20 ng/ml) of age 2 – 59 months 
admitted in emergency or pediatric ward, Mayo 
Hospital, Lahore between December 2014 to May 
2015 were included in this randomized clinical trial 
after approval from the Mayo hospital ethical 
committee through non-probability purposive 
sampling. Sample size of 200 patients (100 in each 
group) was calculated by using 80% power, 95% 
confidence level, 9% absolute precision and 0.05 
level of significance and by taking expected 
percentage of repeat episode of pneumonia in patients 
who were given and not given vitamin D as 45% and 
58% respectively.[10] Patients having very severe 
disease (total  score >2), acute asthma, tuberculosis, 
congenital heart disease (CHD) or any of these is 
suspected after examination, severe acute 
malnourished and those already on vitamin D 
supplements or have normal vitamin D level (>20 
ng/ml) were excluded. After written informed 
consent from the parents, age, gender, height, weight, 
relevant history and physical exam, all the findings 
were documented and blood sample was sent to 
check vitamin D level along with other required lab 
and radiological investigations. Using computer table 
generated numbers, children were randomly assigned 
a group i.e. the group A and group B. Patients in 
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group A  received intramuscular one lakh units of 
vitamin D on the first day of hospital treatment in 
addition to antibiotics. Children of the other group B 
only received suitable antibiotics. Any improvement 
or deterioration in the condition of the patient was 
noted. Patients with normal respiratory rate for age 
and no intercostal and subcostal recessions were 
discharged. All of these were kept on regular follow-
up in the next three months for any recurrence of 
symptoms. The mother was trained during the 
hospital stay to detect tachypnea and chest in drawing 
in the child at home. 
 
RESULTS: 
Of the total 200 patients, the mean age was 7.5 month 
whereas SD, median and range among both the 
groups were nearly same. Each group had equal 
number of patients. The male to female ratio was 
1.6:1, males n=122 (61%) and females n=78 (39%). 
Predominant symptoms at presentation were 
tachypnea (99%), chest indrawings (43%), cough 
(94%) and fever (85%). Symptoms were equally 
distributed in both the genders. Irrespective of gender 
the illness duration before admission was 3.5 days. 
Mean respiratory rate in both genders was fairly 
equal. On clinical examination, 68.5% patients had 
crepitation in chest. 
 
While examining each patient, 36% had no 
malnutrition, 25% had grade I malnutrition and 39% 
grade II malnutrition. Homogenous consolidation of 
the lungs was seen on chest x-ray of more than fifty 
percent patients (Figure 1).The respiratory rate and 
chest auscultation at the time of discharge of both 
groups were normal. Mean of hospital stay was 5.7 
days in the interventional group whereas 6.1 days for 
non-vitamin D group. It clearly shows that patients 
on vitamin D supplementation had lesser duration of 
hospital stay (Table 3.1), with a p value of 0.28 (non-
significant).  
 
Figure: 1: Showing Chest X Ray Findings In The Patients 
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TABLE – 1: Table showing comparison of hospital stay between two groups 
 Hospital stay (days) 
Mean p   SD Median Range  
Vitamin D 
group 
5.7 0.28 2.7 5.3 1.3-14.7 
No vitamin D  6.1 2.8 5.7 1.1-14.4 
Total 5.9 - 2.8 5.7 1.1-14.7 
 
TABLE 2: COMPARISON OF PATIENTS WITH REPEAT EPISODES OF PNEUMONIA BETWEEN 
THE INTERVENTION AND NON-INTERVENTION GROUPS 
 Intervention No. % Chi sq.  P 
1st month Vitamin D given 4 4  
10.0 
 
0.002 
No vitamin D 18 18 
Total 22 22 - - 
2nd month Vitamin D given 4 4  
1.4 
 
0.23 
No vitamin D 8 8 
Total 12 12 - - 
3rd month Vitamin D given 0 0  
2.0 
 
0.16 
No vitamin D 2 2 
Total 2 2 - - 
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Table 3.2 shows the follow up of patients after 
discharge after 1st, 2nd and 3rd month for any 
episode of lower respiratory tract infection. During 1st 
month, 22/200 children had recurrence of pneumonia 
including 4 cases receiving vitamin D therapy vs 18 
children in the other group. P value was calculated 
and came significant (p=0.002). 
 
On further follow-up, 12 patients came with 
symptoms of respiratory tract infection in the second 
month; 4 in vitamin D group and 8 in other group 
(p=0.23). Similarly in 3rd month two patients not of 
the control group came with symptoms of respiratory 
infection, (p value = 0.16). As a whole, the 
recurrence of pneumonia or lower respiratory tract 
infection symptoms was more in the group of patients 
who were not given vitamin D3 (14%) as compared to 
the group of patients receiving vitamin D3 (4%). 
 
DISCUSSION: 
In our study, average age of patients having 
pneumonia was 7.5 months. Demographic survey of 
Pakistan showed age of presentation of children with 
pneumonia is 6 to 11 months.[15]  In this study, male 
to female ratio was 1.6:1, which is in contrast to the 
other studies with no difference in gender 
distribution.[8, 10] The demographic survey of 
Pakistan also showed no difference among male and 
female children with pneumonia.[15] The cause of 
male predominance may be due to social setup with 
lesser number of female children brought for 
treatment. 
 
Tachypnea, cough and fever, these were the major 
symptoms with which patients with admitted. Most 
of these had crepitation in the chest.[1,16] . This 
study showed very few children with bronchial 
breathing and decreased air entry.[1]  
 
Nearly 2/3rd of the patients were malnourished 
showing direct relation of pneumonia with nutritional 
status of a child. The more the child is malnourished 
more are the chances of pneumonia.[17, 18, 19, 20] A 
study showed that the proportion of moderately 
malnourished children included in the studies was 
around 25%.[21] Another study conducted at 
Peshawar, showed 35% children had malnutrition, 
33% with grade I and 43% with grade II malnutrition 
which were comparable with this study.[22] 
 
In this study, treatment protocol followed for 
pneumonia management was almost same for all the 
patients to remove bias. This clinical trial showed 
that vitamin D given with treatment of lower 
respiratory tract infection reduces the risk of 
recurrence of symptoms over three months. Still the 
duration of treatment in hospital till discharge was 
not almost same for all the patients. At the end of the 
study we came with a conclusion that vitamin D 
given in any dose during treatment have no 
significant role in early recovery from disease, but 
will decrease the chances of recurrence of symptoms. 
Our results were close to many other clinical trials 
done previously.[10, 12]  
 
A study conducted in Kabul also proved the 
preventive role of vitamin D supplements in young 
patients with lower respiratory tract infection and 
decreases the risk of recurrence of symptoms for a 
quarter of a year. The risk of recurrence of symptoms 
was more (58%) in placebo group compared to the 
vitamin D group (45%).[10] In a review article on the 
role of vitamin D supplementation in children with 
lower respiratory tract infection, Charan et al 
concluded in favor of vitamin D supplementation as 
it decreases the chances of infections and vitamin D 
deficiency increases the risk of respiratory 
infections.[9] Another study conducted in Japan 
showed significant decline in influenza among school 
children.[23] In two different studies one in India and 
other in Afghanistan vitamin D supplementation in 
pneumonia patients showed no effect on the recovery 
time.[8, 14]  
 
Das R et al compared single dose vs multiple daily 
doses of vitamin D.[14] Many studies showed that 
daily dose schedule shows a better therapeutic effect 
than a large bolus dose, daily doses were more 
effective.[24, 25, 26, 27] 
 
This study supports the prevention given by vitamin 
D from infections bus enhancing immunity. Studies 
shows that the biologically active metabolite of 
vitamin D promotes immune response of the 
body.[28, 29] 
 
Prevention of recurrence of infections in children 
improves overall body state and reduces the disease 
burden. In this clinical trial, all variables were closely 
accessed by trained doctors and pneumonia was 
diagnosed by using both the IMCI criterion and 
reporting of chest x-rays from radiologists. Previous 
clinical trials either took clinical or the radiographic 
changes in the diagnosis of pneumonia.[8, 10, 11, 30] 
This clinical trial was one of the very first controlled 
trials carried out in our country to prove the 
protective role of vitamin D in young patients of 
lower respiratory tract infection. 
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CONCLUSION: 
Our randomized clinical trial proved the preventive 
role of vitamin D supplementation (100,000 IU) in 
the recurrence of lower respiratory tract infections 
among patients of childhood category. Vitamin D can 
help a child for a little early recovery (although not 
statistically significant). As significant number of 
Pakistani children are vitamin D deficient, and 
develop frequent episodes of pneumonia, 
administering vitamin D may help to decrease the 
morbidity and mortality. However, clinical trials on a 
much larger scale are required for more evidence. 
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